Bioxyne Limited (ASX:BXN)
Australia · Delayed Price · Currency is AUD 0.0400
+0.0020 (5.26%)
Nov 5, 2025, 4:10 PM AEST
Bioxyne Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2016 - 2020 |
Operating Revenue | 28.43 | 9.33 | 5.15 | 0.46 | 2.11 | Upgrade |
Other Revenue | 0.85 | 0.32 | 0.14 | - | 0.09 | Upgrade |
| 29.28 | 9.64 | 5.3 | 0.46 | 2.2 | Upgrade | |
Revenue Growth (YoY) | 203.66% | 81.97% | 1042.88% | -78.97% | -5.61% | Upgrade |
Cost of Revenue | 18.1 | 5.93 | 3.73 | 0.33 | 1.25 | Upgrade |
Gross Profit | 11.18 | 3.72 | 1.57 | 0.13 | 0.95 | Upgrade |
Selling, General & Admin | 4.23 | 3.64 | 2.69 | 0.49 | 1.19 | Upgrade |
Research & Development | 0.17 | 0.72 | - | - | 0.09 | Upgrade |
Operating Expenses | 6.08 | 4.85 | 3.38 | 0.59 | 1.32 | Upgrade |
Operating Income | 5.1 | -1.13 | -1.82 | -0.45 | -0.37 | Upgrade |
Interest Expense | - | - | - | - | -0 | Upgrade |
Interest & Investment Income | 0.02 | 0.02 | 0 | - | 0.02 | Upgrade |
Currency Exchange Gain (Loss) | - | - | 0.04 | 0 | -0.03 | Upgrade |
Other Non Operating Income (Expenses) | -0.22 | -0.21 | -0.04 | -0 | -0.1 | Upgrade |
EBT Excluding Unusual Items | 4.9 | -1.32 | -1.82 | -0.45 | -0.5 | Upgrade |
Impairment of Goodwill | - | -11.57 | - | - | - | Upgrade |
Gain (Loss) on Sale of Assets | - | -0.08 | - | - | - | Upgrade |
Asset Writedown | - | - | -0.1 | -0.04 | - | Upgrade |
Pretax Income | 4.9 | -12.97 | -1.92 | -0.49 | -0.5 | Upgrade |
Earnings From Continuing Operations | 4.9 | -12.97 | -1.92 | -0.49 | -0.5 | Upgrade |
Earnings From Discontinued Operations | - | -0.53 | -0.05 | - | - | Upgrade |
Net Income to Company | 4.9 | -13.5 | -1.96 | -0.49 | -0.5 | Upgrade |
Minority Interest in Earnings | - | 0.18 | 0.02 | - | - | Upgrade |
Net Income | 4.9 | -13.33 | -1.94 | -0.49 | -0.5 | Upgrade |
Net Income to Common | 4.9 | -13.33 | -1.94 | -0.49 | -0.5 | Upgrade |
Shares Outstanding (Basic) | 2,078 | 1,930 | 1,344 | 732 | 640 | Upgrade |
Shares Outstanding (Diluted) | 2,150 | 1,930 | 1,344 | 732 | 640 | Upgrade |
Shares Change (YoY) | 11.36% | 43.61% | 83.52% | 14.42% | - | Upgrade |
EPS (Basic) | 0.00 | -0.01 | -0.00 | -0.00 | -0.00 | Upgrade |
EPS (Diluted) | 0.00 | -0.01 | -0.00 | -0.00 | -0.00 | Upgrade |
Free Cash Flow | 4.21 | -3.74 | -1.19 | -0.57 | 0.05 | Upgrade |
Free Cash Flow Per Share | 0.00 | -0.00 | -0.00 | -0.00 | - | Upgrade |
Gross Margin | 38.17% | 38.53% | 29.55% | 29.10% | 43.13% | Upgrade |
Operating Margin | 17.41% | -11.75% | -34.32% | -97.72% | -16.97% | Upgrade |
Profit Margin | 16.74% | -138.19% | -36.61% | -106.55% | -22.49% | Upgrade |
Free Cash Flow Margin | 14.37% | -38.77% | -22.45% | -122.27% | 2.41% | Upgrade |
EBITDA | 5.4 | -1.08 | -1.71 | -0.42 | -0.36 | Upgrade |
EBITDA Margin | 18.45% | -11.22% | -32.25% | -91.09% | -16.17% | Upgrade |
D&A For EBITDA | 0.3 | 0.05 | 0.11 | 0.03 | 0.02 | Upgrade |
EBIT | 5.1 | -1.13 | -1.82 | -0.45 | -0.37 | Upgrade |
EBIT Margin | 17.41% | -11.75% | -34.32% | -97.72% | -16.97% | Upgrade |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.